Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
Abstract
Cigarette smoking is reported in about one third of adults worldwide. A strong relationship between cigarette smoke exposure and chronic obstructive pulmonary disease (COPD) as well as lung cancer has been proven. However, about 15% of lung cancer cases, and between one fourth and one third of COPD cases, occur in never-smokers. The effects of cigarette smoke on the innate as well as the adaptive immune system have been widely investigated. It is assumed that certain immunologic features contribute to lung cancer and COPD development in the absence of smoking as the major risk factor. In this article, we review different immunological aspects of lung cancer and COPD with a special focus on non-smoking related risk factors.
Related Papers
- Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 2 shared tags
- A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 2 shared tags
- Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunctionBrain Behavior and Immunity · 2020 · 2 shared tags
- The Interplay Between Obesity and Venous Thromboembolism: From Molecular Aspects to Clinical IssueInternational Journal of Molecular Sciences · 2025 · 2 shared tags
- The Furin-S2′ Site in Avian Coronavirus Plays a Key Role in Central Nervous System Damage ProgressionJournal of Virology · 2021 · 2 shared tags
- THIRTY YEARS OF PUBLISHED RESEARCH ON HUMAN HEALTH EFFECTS OF EXPOSURE TO THE INTERIOR ENVIRONMENT OF WATER-DAMAGED BUILT ENVIRONMENTS